info@edpo.com
GDPR Compliance Health Care: Key Considerations for Clinical Trials
GDPR compliance health care is a critical requirement for US sponsors conducting clinical trials involving EU or UK participants. As clinical research increasingly relies on cross-border data flows, ensuring healthcare data protection and alignment with EU data protection healthcare regulations is essential. Failure to comply with GDPR can result in significant legal, financial, and reputational risks for organizations operating internationally.
What is GDPR and why does it matter for health care?
Clinical trials inherently involve the processing of sensitive personal data, including health-related information. Under GDPR, this type of data falls under special categories requiring enhanced protection.
US sponsors must comply with GDPR when:
- They collect or process data from individuals located in the EU or UK
- They monitor behavior (e.g., trial participation, biometrics, tracking)
- They collaborate with EU-based investigators or institutions
This makes clinical trials data GDPR compliance non-negotiable, even for companies without a physical presence in Europe.
Key GDPR Compliance Obligations for US Sponsors
To ensure full GDPR compliance health care, US sponsors must implement several core measures:
- Appoint an EU and/or UK GDPR Representative when required
- Establish a lawful basis for processing (e.g., consent, public interest in research)
- Ensure transparency through clear privacy notices
- Implement strong healthcare data protection safeguards
- Maintain records of processing activities (ROPA)
- Conduct Data Protection Impact Assessments (DPIAs) for high-risk processing
Failure to meet these obligations can expose sponsors to enforcement actions from EU regulators.
The Role of EU and UK GDPR Representatives
Non-EU organizations involved in clinical trials must often appoint a local representative under Article 27 GDPR.
A representative:
- Acts as a point of contact for supervisory authorities
- Facilitates communication with data subjects
- Supports regulatory compliance and documentation
Learn more about our services:
International Data Transfers in Clinical Trials
Transferring clinical trial data from the EU to the US is heavily regulated under GDPR.
To ensure lawful transfers, organizations must rely on approved mechanisms such as:
- Standard Contractual Clauses (SCCs)
- Adequacy decisions (if applicable)
- Additional safeguards (encryption, pseudonymization)
US sponsors must also assess the legal environment of the destination country and implement supplementary measures where necessary.
Managing Data Breaches and Risk Exposure
Data breaches in clinical trials can have severe consequences due to the sensitivity of health data.
Organizations must:
- Detect and report breaches within 72 hours
- Notify affected individuals when risks are high
- Maintain incident response procedures
Learn more:
- Data Breach Notification Support
Strengthening Trust Through GDPR Compliance Certification
Demonstrating GDPR compliance health care is not only about avoiding penalties — it is also a strategic advantage.
A compliance certificate:
- Builds trust with partners, regulators, and participants
- Demonstrates accountability and transparency
- Supports faster collaboration with EU institutions
Discover more:
- Compliance Certificate
Practical Steps for GDPR Compliance in Clinical Trials
To operationalize compliance, US sponsors should:
- Map all data flows related to clinical trials
- Identify roles (controller vs processor)
- Appoint representatives where required
- Implement technical and organizational safeguards
- Regularly audit compliance processes
These steps ensure sustainable and scalable GDPR compliance in complex research environments.
Frequently Asked Questions about GDPR in Clinical Trials
GDPR compliance in health care refers to the application of EU data protection rules to medical and health-related data. It requires strict safeguards, transparency, and accountability when processing sensitive patient information.
No. HIPAA and GDPR have different scopes and requirements. While HIPAA focuses on US healthcare data protection, GDPR imposes broader obligations, including data subject rights and international transfer restrictions.
Yes, if they process personal data of individuals in the EU and have no establishment there. Article 27 requires the appointment of a local representative in such cases.
You must use approved transfer mechanisms such as Standard Contractual Clauses and implement additional safeguards like encryption and risk assessments.
CTA (keep consistent):
Contact EDPO to ensure your GDPR compliance in health care and EU/UK clinical trials.
5 essential steps for GDPR compliance in the health care industry
What is the GDPR? The General Data Protection Regulation (GDPR) came into force on May 25, 2018, replacing the 1995 Data Protection...
Fine of 525,000 euros imposed on non-EU company for failure to appoint EU Representative
UNOFFICIAL ENGLISH TRANSLATION DUTCH DATA PROTECTION AUTHORITY – NEWS...
GDPR Compliance for SaaS Companies: What You Need to Know
GDPR SaaS compliance is a critical requirement for any software-as-a-service company processing personal data of individuals located in the...
About the author
Jane Murphy
